Strattera 25 Eli Lilly — Research Summary
Strattera 25 Eli Lilly is a pharmaceutical-grade preparation containing atomoxetine hydrochloride, a selective norepinephrine reuptake inhibitor (SNRI) manufactured by Eli Lilly and Company. This compound represents a unique class of pharmaceuticals that researchers examine for its distinctive mechanism of action in neurochemical pathways. Available from Stroid UK Shop, this laboratory-grade material enables in-depth studies of norepinephrine transporter modulation and its downstream effects on neurotransmitter systems. Unlike traditional stimulant compounds, atomoxetine demonstrates selectivity for norepinephrine reuptake inhibition without direct effects on dopamine transporters in the striatum, making it valuable for neurochemical research applications.
Research Applications
Research scientists investigate atomoxetine for its role in norepinephrine neurotransmission studies and neuroplasticity research. The compound’s mechanism involves blocking the presynaptic norepinephrine transporter, resulting in increased extracellular norepinephrine concentrations in brain regions rich in noradrenergic innervation. Researchers examining atomoxetine preparations often focus on its effects in prefrontal cortex models, where it demonstrates enhanced norepinephrine signalling. Studies evaluate its potential neuroprotective properties and examine molecular pathways involving BDNF expression and synaptic plasticity. The compound’s oral bioavailability and well-characterised pharmacokinetic profile make it suitable for controlled laboratory investigations comparing its effects with other neurotransmitter modulators found in selective receptor modulators and peptide-based research compounds.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Atomoxetine Hydrochloride |
| Manufacturer | Eli Lilly and Company |
| Strength | 25mg per unit |
| CAS Number | 82248-59-7 |
| Molecular Formula | C₁₇H₂₁NO·HCl |
| Molecular Weight | 291.82 g/mol |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance Statement
Strattera 25 Eli Lilly is supplied exclusively for in-vitro research and analytical purposes. This material is not intended for human consumption, therapeutic use, or any application outside of controlled laboratory environments. Researchers must ensure compliance with applicable regulations governing the use of pharmaceutical compounds in research settings. All studies should be conducted by qualified personnel in appropriately equipped facilities with proper safety protocols and documentation procedures.
